The Predictive Value of Retinal Vascular Signs for Intracranial Artery Stenosis (RVS-ICAS)
RVS-ICAS
1 other identifier
observational
1,000
1 country
2
Brief Summary
Intracranial artery stenosis (ICAS) is a leading cause of ischemic stroke worldwide, contributing to the global burden of stroke, particularly in the Asian population. However, there is no non-invasive, easy to popularize and economic for intracranial artery stenosis in mass population screening. This study aims to evaluate the predictive value of retinal vascular signs for intracranial artery stenosis (ICAS) and explore a new screening method.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2022
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 26, 2022
CompletedStudy Start
First participant enrolled
February 27, 2022
CompletedFirst Posted
Study publicly available on registry
March 8, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 26, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2022
CompletedMarch 8, 2022
February 1, 2022
4 months
February 26, 2022
February 26, 2022
Conditions
Outcome Measures
Primary Outcomes (4)
Sensitivity
Number of true positives /(number of true positives + number of false negatives)\*100
6 months
Specificity
Number of true negatives /(number of true negatives + number of false positives)\*100
6 months
Positive predictive value
Positive predictive value = true positive cases /(true positive cases + false positive cases)\*100
6 months
Negative predictive value
Negative predictive value = number of true negatives /(number of true negatives + number of false negatives)\*100
6 months
Eligibility Criteria
Ophthalmic consultation center
You may qualify if:
- Age≥35
- Accept TCD examination and fundus examination
- Signed informed consent
You may not qualify if:
- Non-atherosclerotic stenosis, such as arteritis, moyamoya disease, arterial dissection, vascular malformation, etc., which were clearly diagnosed.
- Intracranial space-occupying lesions
- Jugular vein and intracranial venous lesions
- Patients with severe cardiac, hepatic, renal disease.
- Life expectancy of less than 1 year due to co-morbid conditions.
- Known pregnancy (or positive pregnancy test), or breast-feeding.
- Pathological myopia fundus changes
- Glaucoma
- Refractive medium turbidity affects fundus observation
- Anterior macular membrane of both eyes
- Papilledema, optic neuritis and optic neuropathy
- Patients who have had internal eye surgery in the last six months (including fundus laser)
- Previous history of internal eye trauma
- Poor image quality of fundus and images
- Any condition which, in the judgment of the investigator, might increase the risk to the patient.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Beijing Tiantan Hospital, Capital Medical University
Beijing, Fengtai District, 100070, China
Xuanwu hospital;Capital Medical University
Beijin, XI Cheng District, 100053, China
Related Publications (6)
Holmstedt CA, Turan TN, Chimowitz MI. Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment. Lancet Neurol. 2013 Nov;12(11):1106-14. doi: 10.1016/S1474-4422(13)70195-9.
PMID: 24135208BACKGROUNDWang Y, Zhao X, Liu L, Soo YO, Pu Y, Pan Y, Wang Y, Zou X, Leung TW, Cai Y, Bai Q, Wu Y, Wang C, Pan X, Luo B, Wong KS; CICAS Study Group. Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese Intracranial Atherosclerosis (CICAS) Study. Stroke. 2014 Mar;45(3):663-9. doi: 10.1161/STROKEAHA.113.003508. Epub 2014 Jan 30.
PMID: 24481975BACKGROUNDWaters MF, Hoh BL, Lynn MJ, Kwon HM, Turan TN, Derdeyn CP, Fiorella D, Khanna A, Sheehan TO, Lane BF, Janis S, Montgomery J, Chimowitz MI; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial Investigators. Factors Associated With Recurrent Ischemic Stroke in the Medical Group of the SAMMPRIS Trial. JAMA Neurol. 2016 Mar;73(3):308-15. doi: 10.1001/jamaneurol.2015.4315.
PMID: 26747792BACKGROUNDFamakin BM, Chimowitz MI, Lynn MJ, Stern BJ, George MG; WASID Trial Investigators. Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis. Stroke. 2009 Jun;40(6):1999-2003. doi: 10.1161/STROKEAHA.108.546150. Epub 2009 Apr 30.
PMID: 19407228BACKGROUNDLondon A, Benhar I, Schwartz M. The retina as a window to the brain-from eye research to CNS disorders. Nat Rev Neurol. 2013 Jan;9(1):44-53. doi: 10.1038/nrneurol.2012.227. Epub 2012 Nov 20.
PMID: 23165340BACKGROUNDCheung CY, Ikram MK, Chen C, Wong TY. Imaging retina to study dementia and stroke. Prog Retin Eye Res. 2017 Mar;57:89-107. doi: 10.1016/j.preteyeres.2017.01.001. Epub 2017 Jan 3.
PMID: 28057562BACKGROUND
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 26, 2022
First Posted
March 8, 2022
Study Start
February 27, 2022
Primary Completion
June 26, 2022
Study Completion
July 1, 2022
Last Updated
March 8, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will not share